Global Furosemide Injection Market Research Report 2022

It is a powerful diuretic, acting on the thick segment of the ascending branch of the myeloid loop.COVID-19 has erupted in the world, and these drugs are in short supply.
Due to the COVID-19 pandemic, the global Furosemide Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Furosemide Injection market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Furosemide Injection landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
20mg/2ml accounting for % of the Furosemide Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Furosemide Injection include AuroMedics, Baxter, Fresenius Kabi, Pfizer, Avet Pharmaceuticals, SteriMax, Hunan Kelun Pharmaceutical, Hainan Huanglong Pharm and Shenyang Guagnda Pharm, etc. In terms of revenue, the global 3 largest players have a % market share of Furosemide Injection in 2021.
This report focuses on Furosemide Injection volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Furosemide Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Furosemide Injection Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
20mg/2ml
40mg/40ml
100mg/10ml
Segment by Application
Hospital
Clinics
Recovery Center
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AuroMedics
Baxter
Fresenius Kabi
Pfizer
Avet Pharmaceuticals
SteriMax
Hunan Kelun Pharmaceutical
Hainan Huanglong Pharm
Shenyang Guagnda Pharm
Shagnhai Harvest Pharamceutical
Chengdu Brilliant Pharmaceutical
Changbaishan Pharmaceutical
CSPC Ouyi Pharm